Soaring Prevalence of Chronic Illnesses Fueling Sales of Transradial Access Devices

With the rising preference of people for radial artery access for interventional procedures, growing incidence of chronic diseases, such as diabetes, surging number of chemotherapy procedures, mushrooming usage of radial access devices in high risk and geriatric patients, and soaring healthcare expenditure, the demand for transradial access devices is shooting up across the world. According to the World Health Organization (WHO), around 422 million people across the world are currently living with diabetes, with the disease claiming nearly 1.6 million lives every year. 

 Access Detailed Report - Transradial Access Devices Market Revenue Estimation Report

Moreover, the transradial access approach provides various advantages over the transfemoral intervention procedure, such as favorable clinical outcomes and low cost. This procedure is also predicted to reduce healthcare expenses, which are rapidly becoming a burden for people residing in developing countries. Many studies have been conducted for determining the advantages of the transradial method for transarterial chemoembolization in cancer, which is majorly responsible for the rising public preference for the transradial access method. This is subsequently propelling the demand for transradial access devices. 

Some of the major application areas of these devices are drug administration, blood transfusion, diagnostics and testing, and fluid and nutrition administration. Out of these, the requirement for these devices was the highest in drug administration applications in the years gone by. This was because of the large-scale adoption of vascular access devices for administering drugs for the treatment of cancer and infections. Clinics and ambulatory care centers (ACCs) and hospitals are the major end users of transradial access devices. 

Amongst these, the usage of these devices was significantly high in hospitals during the last few years and this trend will continue in the upcoming years as well. Geographically, the sales of these devices were the highest in Europe in the past. This was because of the extensive use of transradial intervention (TRI) as a default method for percutaneous coronary interventions (PCI) in the region. In addition, the region witnessed the establishment of several outpatient clinics providing same day discharge by cath labs performing TRI during the last few years.